沃森生物(300142.SZ)发布上半年业绩，归母净利润4316.06万元，同比下降74.69%

Core Insights - Watson Bio (300142.SZ) reported a significant decline in revenue and net profit for the first half of 2025, indicating potential challenges in its business operations [1] Financial Performance - The company achieved an operating revenue of 1.154 billion yuan, representing a year-on-year decrease of 19.47% [1] - The net profit attributable to shareholders of the listed company was 43.1606 million yuan, down 74.69% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 28.4427 million yuan, reflecting an 80.52% year-on-year decline [1] - Basic earnings per share were reported at 0.0273 yuan [1]